Clinical use of Dieletrophoresis separation for live Adipose derived stem cells by Allan Y Wu & David M Morrow
Editor’s Note: Readers are alerted that concerns have been raised over the reliability of the data presented in













































Wu and Morrow Journal of Translational Medicine 2012, 10:99
http://www.translational-medicine.com/content/10/1/99RESEARCH Open AccessClinical use of Dieletrophoresis separation for live
Adipose derived stem cells
Allan Y Wu* and David M Morrow
An erratum article was published for this article. It is available from the following link; http://www.translational-
medicine.com/content/12/1/269.Abstract
Background: Microelectrode dieletrophoresis capture of live cells has been explored in animal and cellular models
ex-vivo. Currently, there is no clinical data available regarding the safety and efficacy of dielectrophoresis (DEP)
buffers and microcurrent manipulation in humans, despite copious pre-clinical studies suggesting its safety. The
purpose of this study was to determine if DEP isolation of SVF using minimal manipulation methods is safe and
efficacious for use in humans using the hand lipotransfer model.
Methods: Autologous stromal vascular fraction cells (SVF) were obtained from lipoaspirate by collagenase digestion
and centrifugation. The final mixture of live and dead cells was further processed using a custom DEP microelectrode
array and microcurrent generator to isolate only live nucleated cells. Lipotransfer was completed using fat graft
enhanced with either standard processed SVF (control) versus DEP filtered SVF (experimental). Spectral photography,
ultrasound and biometric measurements were obtained at post operatively days 1, 4, 7, 14, 30, 60 and 90.
Results: The DEP filter was capable of increasing SVF viability counts from 74.3 ± 2.0% to 94.7 ± 2.1%. Surrogate markers of
inflammation (temperature, soft tissue swelling, pain and diminished range of motion) were more profound on the control
hand. Clinical improvement in hand appearance was appreciated in both hands, though the control hand exclusively
sustained late phase erosive skin breaks on post operative day 7. No skin breaks were appreciated on the DEP-SVF
treated hand. Early fat engraftment failure was noted on the control hand thenar web space at 3 months post surgery.
Discussion: No immediate hypersensitivity or adverse reaction was appreciated with the DEP-SVF treated hand. In
fact, the control hand experienced skin disruption and mild superficial cellulitis, whereas the experimental hand did
not experience this complication, suggesting a possible “protective” effect with DEP filtered SVF. Late ultrasound
survey revealed larger and more frequent formation of oil cysts in the control hand, also suggesting greater risk of
engraftment failure with standard lipotransfer.
Conclusion: Clinical DEP appears safe and efficacious for human use. The DEP microelectrode array was found to be
versatile and robust in efficiently isolating live SVF cells from dead cells and cellular debris in a time sensitive clinical
setting.Background
Automated devices for stem cell processing and isolation
are of great clinical utility to the growing field of bioengin-
eering and regenerative cellular therapy. Adipose derived
stem cells (ADSC) in particular have come under greater
use and scrutiny in regenerative medicine due to: relative
ease of access from liposuction [1], abundance compared to
other tissues [2] and lack of controversy [3]. Heterogeneous* Correspondence: dr.wu@morrowinstitute.com
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distribution, and reproduction in any mediumpopulations of ADSCs are commonly obtained from the
stromal vascular fraction (SVF) of processed adipose tissue.
Currently there are commercial devices capable of isolating
the SVF [4], however no clinical machines to date are cap-
able of separating live versus dead cells. This becomes a
particular problem for immediate clinical cellular therapy
in that concomitant injection of dead cells contributes to
inflammation thereby reducing odds of cell engraftment
and transplantation [5]. Moreover, cellular debris induced
inflammation could pose the further threat of inhibiting
normal differentiation of ADSC [6]. Removal of dead cellstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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http://www.translational-medicine.com/content/10/1/99could be easily achieved with tissue culture incubation and
further purification steps, however, some regulatory agen-
cies, such as the United States Food and Drug Administra-
tion, forbid the use of concomitant cell culture for cellular
therapy to stay within the required limits of “minimal ma-
nipulation” for immediate clinical use [7].
Flow activated cytometry cell separation (FACS) or mag-
netic antibody cell separation (MACS) have also been pro-
posed as a solution, yet these too are fraught with
difficulties of finding FDA approved good manufacturing
process (GMP) antibodies [8]. Other technical concerns are
antibody mediated activation of markers, which in some
cases are actually receptors or mediators of transduction
pathways affecting cell behavior [9]. Additionally, the
process further requires “washing and removing” antibodies
before human use. For all the above reasons, FACS and
MACS in sum are expensive, prohibitively time consuming
and technically challenging beyond the scope of routine
clinical practitioners. A minimally manipulated, facile, non-
labeled and cost efficient method of harvesting live cells
would be of tremendous value to the growing regenerative
medicine field.
Cell separation by dielectrophoresis (DEP) could provide
a method of fulfilling the economic, logistical and regula-
tory criterion laid out above. In simple terms, DEP cell iso-
lation is a method of trapping charged spheroid particles
such as free floating live human cells in a low conducting
medium over a micro-electrode. The micro-electrode in
turn is connected to an oscillating current generator at spe-
cific functional frequencies. Interestingly, dead cells do not
express or exhibit a surface charge, as cellular ion channels
are no longer active. Dead cells can therefore essentially be
washed through a DEP device, while live cells may be cap-
tured by a field of the dielectric Force (FDEP) created by an
array of micro-electrodes (Figures 1 and 2) [10].
The “capture” force (FDEP) exerted on a charged cell in
this clinical context may be defined mathematically as:
FDEP ¼ 2πR3ε1 Re K wð Þ½ f g∇E2
In simple terms this means that FDEP is related to size
(πR3) and polarizability (2Re[K(w)]) of the cell, permittivityFigure 1 Schematic drawing of microelectrodes (black rectangles) tra
in the absence of any laminar flow across the array.(ε1) of the suspension medium and gradient of the electric
field (∇E2) applied to the device. By manipulating these
parameters it is possible to either trap or repulse cells at
will [11].
Historically DEP found initial use in the biotech industry
for massive-scale tissue culture processing systems [12].
Only recently has DEP been utilized to experimentally iso-
late discrete cell types such as: blood [13], marrow [14],
spermatozoa [15], oocytes [16], ADSC and neuronal pro-
genitor cells [17]. While DEP has not been shown to detri-
mentally affect viability of cells in culture [18], DEP
isolated cells have never been utilized for direct human
use in any clinical application at the time of this publica-
tion. To simply assume in-vitro data can be extrapolated
to human use may not be correct, since intermittent ex-
posure to high residual electro-oxidized carbohydrates
may ultimately diminish tissue engraftment and SVF func-
tion in-vivo [19,20]. Therefore, the purpose of this study is
to determine if DEP isolated SVF is comparable in safety
and efficacy to conventional SVF obtained by simple cen-
trifugation in the hand atrophy model.
Methods
Consents
Written consent was obtained for the procedure in
addition to consent for enrollment into a clinical trial.
Consent forms and experimental protocol were reviewed
and unanimously approved by an independent IRB (FWA
#A00013119). Consent and procedure was performed at a
State sanctioned hospital in Mexico cleared for thera-
peutic autologous stem cell therapy by the Subsecretaría
de Regulación y Fomento Sanitario Secretaría de Salud of
the United Mexican States.
Construction of device
The dielectrophoresis filter was constructed from ITO
conductive glass and etched by a high precision laser to
produce an inter-digitating microelectrode pattern in a
planar array (Figure 3), and further modified to tolerate
high concentration processing without cell clumping or
parasitic FDEP “traps”. The microelectrode width was 50pping a stem cell (green sphere) within a DEP field (dotted lines)
Figure 2 Schematic drawing of `microelectrodes (black rectangles) trapping a stem cell (green sphere) within a DEP field (dotted lines)
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http://www.translational-medicine.com/content/10/1/99microns, whereas the gap space between electrodes was
100 microns. The microelectrode was then sandwiched
between custom ¼ inch Plexiglas plates with a 0.2 mm
PDMS gasket to form a sealed space above the planar
array. An alternating signal generator to allow a dynamic
range of 2 kHz to 1 MHz and a Vp-p maximum of 15
volts was custom manufactured specifically for this clin-
ical application. Waveforms were confirmed real time
using a TektronixW TDA640 oscilloscope throughout cell
isolation steps. The entire filter was mounted on an
inverted microscope stage to observe capture real time.
DEP isolation parameters
A low ionic, high carbohydrate media supplemented with
antioxidants was used as manipulation buffer for the de-
vice. Conductivity was adjusted to 30 micro Sieverts and
the buffer was sterile filtered (0.45 micron 43052 Corning,Figure 3 Photograph of DEP array prior to sterile packaging into clinCorning NY). The generator was set within a frequency
range from 100 to 1,000 kHz and the chamber flow rate
through the filter regulated at 2 cc/min. A soak cycle of 10
minutes was allowed prior to final specimen collection.
Cells were washed and centrifuged twice in sterile normal
saline. Final pellet was resuspended in 2.5 cc of sterile nor-
mal saline prior to being admixed with purified fat.
Tissue collection and processing
To minimize risk of “wet mess” contamination, routine
ice bagging for preliminary regional anesthesia was
avoided in favor of skin cooling with dry ice blocks
wrapped in a custom sterile thermal restrictive material,
which limited cooling to 4o Celsius. All procedures, tis-
sue and cell handling were carried out at room
temperature. Infiltration and liposuction was performed
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http://www.translational-medicine.com/content/10/1/99hole 4 mm bullet tip cannula. Vacuum extraction was
regulated at a negative pressure maximum of 350 mmHg
throughout the procedure. A total of 400 cc of fat and
600 cc infranatant was obtained. Only washed fat was
used for the study (infranatant was discarded). A total of
6 × 108 viable SVF cells were isolated from a 200 cc ali-
quot of fat, which were pelleted and resuspended in a
volume of 5 cc of DEP buffer. Following DEP processing,
7 × 106 viable nucleated cells were obtained and admixed
into washed, but not collagenase treated, fat for cell
assisted lipotransfer.
Fat was washed in a closed sterile system using sterile
normal saline serially x3. Half of the washed fat was
reserved for later processing. The other half was treated
with collagenase enzyme (Custom Compounding, Los
Alamitos CA) to dissociate the SVF from the adipose tis-
sue [21]. Pelleted SVF cells were then suspended in
25 cc of normal saline, of which half was used for stand-
ard therapy and the remaining further processed using
the experimental device under isolation parameters sta-
ted above. Control SVF was incubated for the same
amount of time with the same amount of DEP buffer as
the experimental protocol. Both control and experimen-
tal SVF were washed, centrifuged, repelleted and recon-
centrated to 1 × 106 cells/mL in endotoxin free plastic
ware (BT 1024, 1210; BP 1003-B Biomed Resource,
Riverside CA, www.bmres.com). A small 100 uL aliquot
sample was obtained from both SVF suspensions for cel-
lular assays prior to being mixed back with purified non-
digested fat. Fat and SVF was mixed by gentle nutation
for 20 minutes prior to injection.
Viability
In a sub-experiment we evaluated the effects of saline,
DEP buffer and presence of an applied electric field on
SVF viability using matching time intervals and fre-
quencies to that of the clinical protocol. The test sam-
ple aliquot was divided evenly into three sets: 1. saline
control 2. DEP buffer 3. DEP buffer with applied
current and 4. DEP buffer with applied current in “live
capture” mode with a dead cell washout. Samples were
perfused into separate but equivalent microelectrode
array cartridges and eluted from the chamber using
matched suspension fluids. All cells were collected and
processed for Trypan blue dye exclusion. The experi-
ment was replicated times three the same day and
counted by the same observer.
Flow cytometry
Aliquots of pre- and post-DEP treated cells were analyzed
by Guava-PCA flow cytometry using ViaCount(R) (Milli-
pore 4000–0040 LOT 11–0115) reagent or monoclonal
anti-human CD34 directly conjugated to phycoerythrin
(R&D Systems FAB7227P LOT: ACOG01) according tomanufacturer protocol. A minimum of 10,000 events were
counted for each sample. Flow data was analyzed by Guava
ExpressPlus software (Millipore). For CD34 expression,
total counts were corrected by subtracting cells reactive to
isotype control. CD34+ cells were then enumerated as a
percentage of corrected total counts.
Lipotransfer
Hand atrophy correction is an experimental model well
suited for this study for the following reasons: 1. two
sites (left or right hand) may be used for either control
or experimental treatment whereby 2. the patient func-
tions as their own internal control and 3. minimal fat is
required for harvest and processing.
One month prior to surgery patient was tested for
hypersensitivity to experimental buffer with a 1.0 cc
wheal beneath the skin on the antecubitum. No reaction
was appreciated and anergy panel testing was negative.
Enhanced fat grafts using either control SVF or DEP
treated (experimental) SVF were transferred using a
2 mm blunt tip cannula with a single side port. Entry
into the subdermal space was made by a single 16’ nee-
dle puncture at the wrist to allow passage of the transfer
cannula. The patient and surgeon were blinded to the
status (experimental vs. control) of the graft. Enhanced
fat graft was distributed by serial fanning method using
minimal pressure on withdrawal to deploy a thin ribbon
of graft while avoiding vessels and tendinous sheaths of
the hand. Over correction by 20% was performed bilat-
erally as this is customary standard of care. Immediate
post operative photo documentation was obtained. Steri-
stripsW were used to close puncture sites and hands were
wrapped in loose Kerlex gauze.
Standardization of photography
Of great concern in photographing patients being trea-
ted for hand atrophy is visual biasing secondary hand
and digit position. For example: fully extending the
digits on a preoperative photograph will accentuate a
skeletonized appearance, whereas non-extension in the
post-operative photograph will appear near normal. In
some patients this biased positioning is enough to cre-
ate the false appearance of atrophy correction even
without surgical intervention. For this reason we devel-
oped a standardized method of photographing the
hands as follows:
1. the patient is placed in the sitting position facing a
blue/green photography wall, such that the hips are
flexed at 90 degrees and knees touching the wall,
2. arms are fully extended directly forward to the
patient
3. palms are placed on wall creating 45 degree angle
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http://www.translational-medicine.com/content/10/1/994. inter-hand distance is to be no wider than the width
between shoulders
5. digits are then photographed in the following
positions:
a. fully extended,
b. closed with thenar at 90 degrees relative to other
digits
6. multispectral images for detailed skin evaluation are
obtained by VisiaW (Canfield, Fairfield NJ), an
automated photodocumentation system, with the
hand in a closed fist position and touching the top
reference bar.Biometric measurements
Patient was measured for extension range of motion in
her wrist and digits using specialty goniometers pre- and
post-operatively, with the entire antecubetum held flush
with the table. Circumference was taken at the base of
each digit with a finger circumference gauge. Average
circumference was calculated by taking the sum of each
digit for each hand and dividing by 5. Thermocouple
readings were performed on the center dorsum of the
had at room temperature (DigisenseW Thermocouple,
Cole-Palmer, Bunker CT). Readings were obtained after
3 minutes of equilibration with the metal lead.Results
Case description
Case #72-001: Patient was a 69-year-old Caucasian female
(BMI 29) and reformed smoker experiencing repetitive
skin breaks echymosses and trauma to dorsum of hands
secondary to thinning of the skin. She was also unsatisfied
with the skeletonized appearance on the dorsum of her
hands. Old scars (hypopigmented hyperkeratotic lesions)
from inadvertent abrasions and ruptured skin from trau-
matic echymosses were appreciated on pre-operative
evaluation. One year of routine high emollient topical skinFigure 4 Percent viability measured by Trypan dye exclusion versus ttherapy was unsuccessful. Recurrent ease of trauma began
to affect her ability to carry out normal hand function and
activities of daily living. Conventional dermal fillers were
also offered as temporizing therapy, however, the patient
reported a history (three years previous) of an adverse reac-
tion to a dermal filler, thus a preference for autologous
therapy. For this reason she requested definitive therapy
with autologous fat transfer. After unblinding at the con-
clusion of the study (3 months following the procedure) a
CA-125 (5 U/mL) and AFP (2 ng/dL) were drawn from
the experimental hand and found to be negative. (Negative
range for our reference laboratory is 35 U/mL for CA-125
and 10 ng/dL for AFP.)DEP effects on viability
Simple perfusion of SVF suspended in normal saline
through the device cartridge produces a baseline viability
of 74.3 ± 2.0% (Figure 4). Buffer without an electric field
yielded 75.4% viability, whereas microelectric current ex-
posure with buffer in whole cell collection mode (i.e. no
washout of dead cells) slightly increased the viability to
76.2 ± 3.1%. Buffer with device in live capture mode dra-
matically increased viability to 94.7 ± 2.1%.DEP effects on biometry readings
Both treatment and control hand experienced a tempor-
ary decrease in extension range of motion of the digits
and wrist. Of interesting note, the digits on the control
hand did not have full return to baseline at the end of
3 months (Figure 5). The control hand also had a slower
rate of return to baseline in goniometry compared to the
DEP treated hand (Figures 5 and 6). Pain also contribu-
ted to the limitation of extension motion and was worse
in the control hand even at rest with NSAID pain medi-
cation (Figure 7). Thermocouple readings from the cen-
ter of the hand also revealed localized temperature























































Figure 6 Goniometry measurements of wrist in maximal extension position post surgery.
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http://www.translational-medicine.com/content/10/1/99the control hand and a slower return to baseline com-
pared to DEP treated (Figure 8). Thermal elevation
appeared 7 days post surgery whereas a goniometry, pain
and finger circumference appeared earlier at 1 day post
surgery (Figures 5, 6, 7, 8 and 9).Flow cytometry data
Viability and CD34 counts are improved with DEP isola-
tion of SVF (Figures 10 and 11). A “cleaning” effect to the
cell population is appreciated after DEP isolation, in that
dead cells and cellular debris are cleared from the sample
(Figures 12, 13 and 14). A more narrow homogeneous
profile and distribution of fluorescence is also appreciated
on forward scatter for CD34 staining in DEP isolated cell
populations (Figure 10). Untreated cells exhibit a bimodal
distribution, whereas DEP isolated cells have a single peak
and narrow bell shaped distribution with considerably
higher CD34 counts. An increase in CD34 levels improved
from 41% to 90%, which is a greater than two-fold increase

















Figure 9 Average finger circumference measured as a function of timDiscussion
To our knowledge, this is the first reported clinical use
of DEP processing of SVF cell therapy in a human. Con-
trary to our original hypothesis, a significant improve-
ment in clinical outcomes was appreciated with the
experimental procedure of the study. Positive benefit
was noted in immediate post-surgical healing parameters
(Figures 5, 6, 7, 8 and 9). Of particular note: post-
surgical skin eruptions and ulcerations occurred only on
the control hand (Figure 15). Location of skin breaks
were highly correlated to RBX filter images showing vas-
cular injection and dilation occurring towards the center
of the hand (Figure 16). This is consistent with other fat
transfers we have performed with and without SVF sup-
plementation in the past (Figure 17). Interestingly, the
experimentally treated hand sustained vascular changes
as well, but to a smaller surface area, yet did not have
any skin breaks or ulcerations despite receiving equal
volumes of enriched fat graft. Moreover, the side with
DEP purified SVF exhibited superior engraftment espe-






Figure 10 Flow cytometry for detection of CD34 cells in DEP isolated SVF (lower panel) versus non-treated SVF (middle panel) and
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http://www.translational-medicine.com/content/10/1/99web space, which is a common site of failure (Figure 18
lower panels).
It is not entirely clear why a clinical difference occurred,
though great efforts were taken to control for similar con-
ditions (i.e. equivalent cell handling and DEP media expos-
ure for both interventions). Measures were also taken to
select a patient with similar appearing hands and endogen-
ous vascularization confirmed by arterial Doppler flow
studies prior to therapy. Both interventions from a clinical
perspective, however, did yield comparable appearingFigure 12 Viability and debris analysis by flow cytometry using ViaCo
un-treated SVF (upper panels). DEP isolated and “cleaned” SVF (lower paneaesthetic results, though the skin consistency of the DEP-
SVF treated hand was palpably more dense with normal
turgor, whereas the control hand retained a parchment like
quality to the skin (Figure 18). Further differences in dee-
per subdermal consistency were also appreciated on ultra-
sound in the control hand, such that oil cysts (an early sign
of graft failure) were appreciated in greater number than
the DEP-SVF treated hand (Figures 19, 20, 21 and 22).
Unexpectedly the patient sustained a minor decrease in
extension capability at the wrist and digits in the controlunt stain. High dead cell and debris (green circles) appreciated in
ls).
Figure 13 Microscopic view (4x inverted microscope phase and green filter) of DEP microelectrode array using higher frequencies to
capture smaller nucleated cells (red circles) 25–40 microns in size within a high debris clinical sample. Darker striped regions are the
electrode domains (approximately 50 microns) whereas the lighter striped regions are the gap space (approximately 100 microns). The direction
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http://www.translational-medicine.com/content/10/1/99hand. Though minor, any functional deficit can have an ex-
ponential effect on an already compromised dexterity, due
to concomitant disease (i.e. arthritic joint disease and tendonFigure 14 Microscopic view (4x inverted microscope phase and green
capture frequency to collect 50 micron cells (red circle) trapped later
Smaller debris and cells (white circles) flow through the chamber and are wcontractures). We have speculated in 30 years of performing
standard lipotransfer of the hand that, in select cases, cellu-
lar debris may contribute to surrounding fibrillary tanglesfilter) of DEP microelectrode array using a different modulating
al to the microelectrode (dark stripe), despite heavy debris field.
ashed free from the captured cells.
Figure 15 69-year-old female status post hand lipotransfer post operative day 7 with DEP treated (left pane) versus control (right
pane). Note eruptions, ulcers and skin breaks (red circles) which occurred exclusively on the control hand. Swelling is more prominent in the
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http://www.translational-medicine.com/content/10/1/99(Figure 23) and eventual fibrosis (Figure 24) surrounding
tendon sheaths, which impairs normal free movement of
the hand. Perhaps this complication may be related to cel-
lular focusing of SVF cells (Figure 25) and the elimination
of cellular debris (Figures 12, 13 and 14) and inflammatory
mediators, which recruit adipose lipophages and other in-
hibitory cells to exacerbate endogenous underlying disease
(i.e. arthritis) [5]. This is suggested indirectly by the higher
thermocouple readings (Figure 8) and other surrogate mar-
kers for inflammation (i.e. finger circumference, pain and
decreased mobility) seen in the control hand. However,
exposure to a DEP field in and of itself could also play a
beneficial role by inducing cell cycle activation of “pre-Figure 16 69-year-old female status post hand lipotransfer procedure
showing regions of inflamed skin (green circles) with DEP (left panel) versu
in the control hand within the inflamed regions, yet no skin breaks or ulceviable” or quiescent (G0) cells, which in a typical transfer
provide no immediate healing functions. Further studies to
disentangle these issues in addition to randomized control
trial studies with the DEP device are currently being con-
ducted at our centers.
Though current beneficial implications of accelerated
healing and improved engraftment are promising, clinical
DEP presents even greater future implications for the field
of regenerative medicine and cell therapy. FDEP can be
modulated in direction (i.e. capture vs. repulsion) and
magnitude. The methodology is also versatile enough to
function at the nano- , micro- and macro- level. This
affords the ability to “tune-in” or “tune-out” specific cellpost operative day 4. Spectral imaging of hands with RBX mode
s control (right panel). Regions of ulceration and skin breaks occurred
rs occurred at any point of the study in the DEP treated hand.
Figure 17 A cohort of hands in women aged 60-73-years-old within 1 week post standard lipotransfer. The typical complication revealing
ulceration and eruptions (green circle) within the center of the hand.
Figure 18 69-year-old female status post hand lipotransfer 3 months post surgery. Before and after images of hands treated with standard
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http://www.translational-medicine.com/content/10/1/99types from the heterogenous composition of SVF, which is
unprecedented and represents the development of a sec-
ond generation tool for regenerative medicine.
A device, such as the one used in this study, could be
used to economically select or subtract cell types to more
precisely define and refine cellular therapies. For example,
breast augmentation using autologous SVF enriched adi-
pose tissue has progressed with clinical results which
continue to improve [22-26], but safety issues such as cal-
cification artifacts interfering with mammogram screening
and the long-term risks of tumorgenesis have been raised
[27]. Additionally, recent epidemiologic data on prosthetic
breast implants suggest foreign bodies within the breast
space may be related to anaplastic large cell lymphoma
(ALCL) as well [28]. Clinical DEP could provide a safer
breast fat graft by removal of osteogenic (calcificationFigure 20 Ultrasound image of left hand (DEP-SVF treated) coronal v
lipotransfer.forming) precursors [29] or CD-30 (ALCL associated)
lymphocytes, which coincidentally can occur in high abun-
dance as a contaminant in SVF (unpublished findings).
Furthermore, DEP is also capable of detecting high nuclear
to cytoplasmic ratio cells and extremely small charged par-
ticles, affording the possibility of “filtering” any graft free of
cancer cells [30,31] or bacteria [32]. DEP can even select
based on cell cycle status, opening the further possibility of
improving cell therapy transplantation rates by transferring
only actively dividing cells [33].
Adipose SVF and ADSC have also found use in sports
medicine, orthopedics and rehabilitation therapy. One par-
ticular treatment showing strong demand is treatment of
damaged or worn cartilage with SVF/ADSC. There are
conflicting reports of efficacy for this indication [34]. In-
advertent simultaneous transplantation of pre-committediew of thenar web space of a 69-year-old female 3 months post
Figure 21 Ultrasound image of right hand (control) saggital view of thenar web space of a 69-year-old female 3 months post
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http://www.translational-medicine.com/content/10/1/99adipose precursor cells within the SVF into articular spaces
could have poor long-term consequences. Recurrent damage
of engrafted ectopic fat on articular surfaces release lipid
and long chain fatty acids. This can be converted into
prostaglandins and other mediators of inflammation (i.e.
adipokines), thus accelerating native cartilage degeneration
[35]. Joint space injections with purified chondrocyte des-
tined cells, minus adipogenic precursors, would be prefer-
able to a random heterogeneous approach currently in use
and presents yet another example of how clinical DEP
could be applied.
In more recent developments, popular media reports of
regenerative medicine utilization by prominent athletesFigure 22 Ultrasound image of right hand (DEP-SVF treated) coronal
lipotransfer. Oil cyst seen in deeper dermis (red circle).(i.e. Peyton Manning, Chad Ochocinco and Terrell Owens)
have created a glamorizing effect to the field. While these
famous cases of stem cell therapy are helpful in raising
awareness, disproportionate attention to the promise, but
not the potential consequences, leave serious concerns of
the public being unfairly biased and indirectly counseled
by dominating modern media and content [36]. Though it
is not the intention of this paper to morally assail any
practitioner or patient, we believe the growing demand for
cellular therapies is reaching critical mass and signifies the
necessity of a clinical paradigm shift from a focus of effi-
cacy, to one of safety. To this end, all second generation
separation technologies, especially DEP, should beview of thenar web space in a 69-year-old female 3 months post
Figure 23 Microscopic image (40X, H and E staining) of fibrillary tangles of cellular debris and adipocyte matrix biopsied from a hand
3 weeks post standard fat transfer. (Previous patient not part of this study.) Note mast cells (green arrows) surrounding cellular debris.
Figure 24 Microscopic image (40X, H and E staining) of engrafted fat with dense fibrosis (white arrow) surrounding nascent fat
globules (black arrow) at 6 months post standard lipotransfer. (Previous patient not part of this study).
Figure 25 40x microscopic image of SVF before (left pane) and after (middle pane) DEP isolation. (Smaller dark particles in middle panel
are unsettled defocused SVF cells.) DEP isolated cells directly plated to Matrigel coated culture dish (right panel) without mechanical filtration at
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http://www.translational-medicine.com/content/10/1/99investigated with a greater sense of urgency to address the
growing immediate need for safety.
Conclusions
Though only one human subject was used for this pilot
study, five independent injections were performed for each
hand web space and no long-term sonographic irregular-
ities (hyperechoic or hypoechoic) were appreciated with
DEP processing. Clinical DEP processing of SVF cells,
therefore, appears to be feasible and safe for use in
humans, and confers an improved healing and engraftment
capability in comparison to standard SVF in the hand lipo-
transfer model. Use of DEP in the clinical setting offers the
promise of a potentially more safe, rational and persona-
lized approach to cellular therapeutics.
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